about
Cannabis-associated psychosis: Neural substrate and clinical impact.Development and Validation of a Clinically Based Risk Calculator for the Transdiagnostic Prediction of Psychosis.What causes psychosis? An umbrella review of risk and protective factors.Can We Reduce the Duration of Untreated Psychosis? A Systematic Review and Meta-Analysis of Controlled Interventional Studies.Diagnostic and Prognostic Significance of DSM-5 Attenuated Psychosis Syndrome in Services for Individuals at Ultra High Risk for Psychosis.Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders.Why transition risk to psychosis is not declining at the OASIS ultra high risk service: The hidden role of stable pretest risk enrichment.Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis.Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis.Long term outcomes of acute and transient psychotic disorders: The missed opportunity of preventive interventionsTransdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk and the Prediction of Psychosis: Second Replication in an Independent National Health Service TrustA Case of a College Student Presenting With Mild Mental Health ProblemsOxytocin modulates hippocampal perfusion in people at clinical high risk for psychosisNeurochemical effects of oxytocin in people at clinical high risk for psychosisTransdiagnostic Individualized Clinically Based Risk Calculator for the Detection of Individuals at Risk and the Prediction of Psychosis: Model Refinement Including Nonlinear Effects of AgePrenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysisUnmet needs in patients with brief psychotic disorders: Too ill for clinical high risk services and not ill enough for first episode servicesCannabidiol as a potential treatment for psychosisTransdiagnostic psychiatry: a systematic reviewPreventive Treatments for Psychosis: Umbrella Review (Just the Evidence)What Causes the Onset of Psychosis in Individuals at Clinical High Risk? A Meta-analysis of Risk and Protective Factors
P50
Q36410800-A50C8D2F-879F-4C4B-B232-AB364508488BQ38868964-0BFFF5D0-F284-4860-A21A-85AB0B05F518Q47547157-E030BF5C-6D8D-4439-AADB-2162B5055F2DQ47551552-34D5659B-FD5A-4431-ABAF-8EFE7E762070Q47719258-AC897E96-F1FF-4A99-95CC-665B56087ADEQ47797109-F0264835-7005-4E3F-9A25-4CF7D467BC9FQ50522582-F597B30E-5A81-472A-A068-147349F1721DQ55361260-C6DFD91A-54B1-4647-A8A1-415CE43D8831Q55397391-4D0C5166-5F12-4351-B5AF-F2191BF1E17DQ57519544-CB4589EF-0E56-4F35-B1BA-435F0E14E620Q57519551-F4A59E3D-FC09-4D5D-B9E3-CB8D267EBD3AQ60242662-399CC345-968A-4971-98AA-230B653D8C0CQ60625022-07B4C55E-61DC-4FD4-9CF4-A3F6F6A65D0CQ62725698-71FC9901-25CE-4E66-9630-08FB300F22F1Q64259737-B88C35AB-63B6-4786-AE20-F37EDF9DC389Q90707526-A7BFE6FB-D1C0-4E00-ADE6-6A2E36E00B52Q91112948-9CD19414-3B37-4DCC-8DA9-FC2FA82738CDQ91333459-F6F4A73C-A37A-4F7C-B3FE-932656BEE0EEQ91790889-58F095E0-4FBA-4C1B-A712-AA06D046D821Q92536141-441F4EC8-6F6B-49A5-8933-20EF47FB7183Q92895356-77E19DDE-1830-4763-9114-43338665D81A
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-3011-8643
@en
name
Cathy Davies
@ast
Cathy Davies
@en
Cathy Davies
@es
Cathy Davies
@nl
type
label
Cathy Davies
@ast
Cathy Davies
@en
Cathy Davies
@es
Cathy Davies
@nl
prefLabel
Cathy Davies
@ast
Cathy Davies
@en
Cathy Davies
@es
Cathy Davies
@nl
P106
P1153
57194102193
P21
P31
P496
0000-0003-3011-8643